Andere talen Celon Pharma S.A.

Aandelen

CLN

PLCLNPH00015

Vertraagde tijd Warsaw S.E. Andere beurzen 15:59:11 04-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
15,68 ^PLN	0,00%		0,00%	+1,42%

17/06	Celon Pharma kondigt de resultaten aan van Fase Ii Klinisch Onderzoek voor Cpl? 116, een Jak/Rock dubbelinhibitor voor de behandeling van reumatoïde artritis (Ra)	CI
22/05	Celon Pharma S.A. rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Celon Pharma Announces Results of Phase Ii Clinical Trial for Cpl? 116, A Jak/Rock Dual Inhibitor in the Treatment of Rheumatoid Arthritis (Ra)	17/06
Celon Pharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/05
Novohale Therapeutics, LLC announced that it expects to receive $30 million in funding from Tang Capital Management, LLC, Celon Pharma S.A.	22/05
Celon Pharma S.A. announced that it expects to receive PLN 40.5 million in funding from Tang Capital Management, LLC	22/05
Celon Pharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04
Celon Pharma S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Celon Pharma S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	20-09-23
Celon Pharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	24-05-23
Celon Pharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	26-04-23
Celon Pharma S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23-11-22
Celon Pharma S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	28-09-22
Celon Pharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	25-05-22
Celon Pharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	02-05-22
Celon Pharma S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29-11-21
The results of CPL’36 – PDE10a inhibitor to be presented in the poster session at Neuroscience 2021.	02-11-21
Celon Pharma S.A. at the Jefferies Healthcare Conference 2021.	26-10-21
Celon Pharma S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	30-09-21
Celon Pharma S A : Doubled export sales, continuation of the strategy of investing in research and development	30-09-21
Celon Pharma S A : 3 posters to be published at 34th ECNP Congress	14-09-21
Celon Pharma Successfully Completes the First Stage of Clinical Research into its CPL'116 Drug Candidate for Treating Autoimmune Diseases	10-08-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Celon Pharma S.A.

Aandelen

CLN

PLCLNPH00015

Andere talen

Filters